Overview

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Status:
Terminated
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.
Phase:
Phase 3
Details
Lead Sponsor:
Avedro, Inc.
Glaukos Corporation
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions
Riboflavin